Hong Kong Pharmaceuticals & Biotech Stocks

  • 7D-6.1%
  • 1Y23.2%
  • Avg. PE15.7x
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
2269WuXi Biologics (Cayman)HK$121.103.5%124.5%HK$513.2bHK$147.52P/E235.6xE27.4%n/a
6185CanSino BiologicsHK$337.0024.7%29.5%HK$127.8bHK$428.59P/S133.1xE22.9%n/a
1548Genscript BiotechHK$34.858.1%110.4%HK$73.1bHK$25.67P/S21.8xE15.0%0%
9995RemeGenHK$99.8012.2%n/aHK$48.9bHK$130.48P/B11.3xE50.3%n/a
1801Innovent BiologicsHK$79.003.6%65.6%HK$115.2bHK$104.28P/S23.2xE53.1%n/a
460Sihuan Pharmaceutical Holdings GroupHK$2.7311.4%241.3%HK$25.8bHK$3.34P/E42.3xE45.7%1.9%
2137Brii BiosciencesHK$25.9015.1%n/aHK$18.3bn/aP/S50.1xn/an/a
9939Kintor PharmaceuticalHK$78.008.3%413.2%HK$30.2bHK$69.50P/B15.9xE75.3%n/a
2162Keymed BiosciencesHK$67.859.9%n/aHK$19.0bn/aP/E-18.7xn/an/a
9926AkesoHK$50.304.4%68.2%HK$41.1bHK$72.63P/S570.2xE70.8%n/a
2171CARsgen Therapeutics HoldingsHK$29.9010.7%n/aHK$17.0bHK$48.72P/E-4.6xn/an/a
6118Austar LifesciencesHK$18.7411.2%380.5%HK$9.6bn/aP/E241.3xn/a0%
570China Traditional Chinese Medicine HoldingsHK$4.853.2%25.0%HK$24.4bHK$5.54P/E12.2xE7.5%0%
2186Luye Pharma GroupHK$4.255.2%-13.4%HK$15.1bHK$5.91P/E15.9xE19.2%0%
1093CSPC Pharmaceutical GroupHK$10.480.6%3.8%HK$125.3bHK$14.11P/E19xE12.5%1.7%
1877Shanghai Junshi BiosciencesHK$52.351.5%2.0%HK$62.3bHK$93.43P/S12.1xE5.4%n/a
1521Frontage HoldingsHK$6.464.9%56.4%HK$13.2bHK$6.64P/E97.5xE24.0%n/a
512China Grand Pharmaceutical and Healthcare HoldingsHK$6.192.5%-30.8%HK$22.0bHK$10.00P/E11.9xS17.6%1.8%
1873Viva Biotech HoldingsHK$8.023.4%-9.0%HK$15.4bHK$10.39P/S15xE23.8%0.3%
1952Everest MedicinesHK$60.252.6%n/aHK$17.9bHK$106.44P/B2.1xE92.6%n/a
1177Sino BiopharmaceuticalHK$6.690.3%-33.1%HK$125.6bHK$11.19P/E27.4xE8.4%1.2%
1167Jacobio Pharmaceuticals GroupHK$18.441.5%n/aHK$14.2bHK$26.05P/S12xS-42.1%n/a
3681SinoMab BioScienceHK$3.356.3%-5.1%HK$3.4bn/aP/S219.6xn/an/a
1349Shanghai Fudan-Zhangjiang Bio-PharmaceuticalHK$4.693.8%-21.0%HK$15.3bn/aP/E21.2xn/a1.3%
Page 1 of 4